Current Status of the Third-Line Helicobacter pylori Eradication.
Current Status of the Third-Line Helicobacter pylori Eradication.
复制标题
DOI:
10.1155/2018/6523653
复制
发表时间:
2018
影响因子:
2
通讯作者:
Baik GH
中科院分区:
文献类型:
--
作者:
Choi JH;Yang YJ;Bang CS;Lee JJ;Baik GH
Antibiotic resistance is growing worldwide, and patients who have failed consecutive 1st- and 2nd-line H. pylori eradication regimens are increasing. Therefore, the role of the bacterial culture with antibiotic susceptibility testing and molecular susceptibility testing is important for avoiding the use of ineffective antibiotics. However, antibiotic susceptibility testing-guided treatment does not necessarily guarantee successful eradication, and there have been mixed results for the effectiveness of a 3rd-line rescue therapy. Therefore, providing patients with pretreatment medication instructions and education is important. It is also crucial to determine the reason of the eradication failure, including host-related factors (poor compliance to eradication regimen, smoking, and cytochrome P450 2C19 genetic polymorphism) or treatment-related factors (inadequate dosage or duration of therapy and gastric acidity), as such factors can be modified for a tailored therapy. Although the indications for H. pylori eradication have widened, patients at a high risk of gastric cancer can gain definitive benefits with a 3rd-line or even 4th-line therapy.
登录
查看更多内容
影响因子:
4.3
作者:
Arslan N;Yılmaz Ö;Demiray-Gürbüz E
通讯作者:
Demiray-Gürbüz E
影响因子:
4.4
作者:
Kim, JJ;Kim, JG;Kwon, DH
通讯作者:
Kwon, DH
影响因子:
2
作者:
Gisbert JP
通讯作者:
Gisbert JP
影响因子:
0.8
作者:
Kim, Jin Young;Moon, Hyo Jung;Jeong, Byeongmoon
通讯作者:
Jeong, Byeongmoon
影响因子:
8.4
作者:
Hirata, Yoshihiro;Serizawa, Takako;Koike, Kazuhiko
通讯作者:
Koike, Kazuhiko